Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Bristol-Myers Squibb Company(BMY) | 703,606 | 688,218 | -15,388 | $38.16M | $28.58M | 26.42% | -$9.57M |
| Biodesix, Inc.(BDSX) | 5,348,273 | 5,696,113 | +347,840 | $7.63M | $8.70M | 8.04% | +$1.07M |
| Elutia Inc.(ELUT) | 1,655,184 | 1,551,655 | -103,529 | $5.21M | $7.70M | 7.11% | +$2.48M |
| Neurocrine Biosciences, Inc.(NBIX) | 77,240 | 42,240 | -35,000 | $10.65M | $5.82M | 5.37% | -$4.84M |
| Silk Road Medical Inc | 158,094 | 158,094 | 0 | $2.90M | $4.27M | 3.95% | +$1.38M |
| Prothena Corp PlcSHS SHS | 169,574 | 203,574 | +34,000 | $4.20M | $4.20M | 3.88% | +$1.4K |
| Acadia Pharmaceuticals Inc | 250,400 | 250,400 | 0 | $4.63M | $4.07M | 3.76% | -$560.9K |
| Ovintiv Inc.(OVV) | 84,200 | 74,200 | -10,000 | $4.37M | $3.48M | 3.21% | -$892.2K |
| United Therapeutics Corporation(UTHR) | 11,000 | 10,000 | -1,000 | $2.53M | $3.19M | 2.94% | +$658.6K |
| Harrow, Inc.(HROW) | 150,000 | 150,000 | 0 | $1.98M | $3.13M | 2.90% | +$1.15M |
| Stoke Therapeutics, Inc.(STOK) | 210,000 | 210,000 | 0 | $2.83M | $2.84M | 2.62% | +$2.1K |
| Phreesia, Inc.(PHR) | 114,700 | 114,700 | 0 | $2.74M | $2.43M | 2.25% | -$313.1K |
| Corcept Therapeutics Incorporated(CORT) | 50,000 | 74,000 | +24,000 | $1.26M | $2.40M | 2.22% | +$1.14M |
| Quidelortho Corp | 65,203 | 67,619 | +2,416 | $3.13M | $2.25M | 2.08% | -$879.5K |
| Masimo Corp | 15,280 | 15,280 | 0 | $2.24M | $1.92M | 1.78% | -$319.5K |
| Foghorn Therapeutics Inc.(FHTX) | 320,930 | 320,930 | 0 | $2.15M | $1.85M | 1.71% | -$308.1K |
| Equitrans Midstream Corporatio | 133,050 | 133,050 | 0 | $1.66M | $1.73M | 1.60% | +$65.2K |
| Protagonist Therapeutics Inc | 48,000 | 48,000 | 0 | $1.39M | $1.66M | 1.54% | +$274.6K |
| Axogen, Inc.(AXGN) | 173,000 | 197,000 | +24,000 | $1.40M | $1.43M | 1.32% | +$30.2K |
| DocGo Inc.(DCGO) | 460,000 | 460,000 | 0 | $1.86M | $1.42M | 1.31% | -$437.0K |
| Alkermes plcSHS(ALKS) | 50,000 | 50,000 | 0 | $1.35M | $1.21M | 1.11% | -$148.5K |
| Travere Therapeutics, Inc.(TVTX) | 122,000 | 122,000 | 0 | $940.6K | $1.00M | 0.93% | +$62.2K |
| Alphatec Holdings, Inc.(ATEC) | 88,000 | 88,000 | 0 | $1.21M | $919.6K | 0.85% | -$293.9K |
| Castle Biosciences, Inc.(CSTL) | 14,000 | 34,000 | +20,000 | $310.1K | $740.2K | 0.68% | +$430.1K |
| Exxon Mobil Corp | 0 | 5,849 | +5,849 | $0 | $673.3K | 0.62% | +$673.3K |
| Progyny Inc | 22,000 | 22,000 | 0 | $839.3K | $629.4K | 0.58% | -$209.9K |
| 10x Genomics, Inc.CL A(TXG) | 30,000 | 30,000 | 0 | $1.13M | $583.5K | 0.54% | -$542.4K |
| Kiniksa Pharmaceuticals Ltd | 30,000 | 30,000 | 0 | $591.9K | $560.1K | 0.52% | -$31.8K |
| Kalvista Pharmaceuticals Inc | 46,000 | 46,000 | 0 | $545.6K | $541.9K | 0.50% | -$3.7K |
| Cytokinetics, Incorporated(CYTK) | 10,000 | 10,000 | 0 | $701.1K | $541.8K | 0.50% | -$159.3K |
| Apellis Pharmaceuticals Inc COM | 18,000 | 14,000 | -4,000 | $1.06M | $537.0K | 0.50% | -$521.0K |
| Halozyme Therapeutics, Inc.(HALO) | 10,000 | 10,000 | 0 | $406.8K | $523.6K | 0.48% | +$116.8K |
| Coherus Oncology, Inc.(CHRS) | 270,000 | 270,000 | 0 | $645.3K | $467.1K | 0.43% | -$178.2K |
| Karyopharm Therapeutics Inc.(KPTI) | 469,832 | 469,832 | 0 | $709.4K | $407.6K | 0.38% | -$301.8K |
| Arvinas, Inc.(ARVN) | 15,000 | 15,000 | 0 | $619.2K | $399.3K | 0.37% | -$219.9K |
| Sarepta Therapeutics, Inc.(SRPT) | 2,500 | 2,500 | 0 | $323.6K | $395.0K | 0.37% | +$71.3K |
| Xenon Pharmaceuticals Inc.(XENE) | 10,000 | 10,000 | 0 | $430.5K | $389.9K | 0.36% | -$40.6K |
| Accelerate Diagnostics Inc | 325,239 | 325,239 | 0 | $322.0K | $380.5K | 0.35% | +$58.5K |
| Springworks Therapeutics Inc | 10,000 | 10,000 | 0 | $492.2K | $376.7K | 0.35% | -$115.5K |
| Cullinan Therapeutics, Inc.(CGEM) | 25,114 | 20,000 | -5,114 | $427.9K | $348.8K | 0.32% | -$79.1K |
| NovoCure Limited(NVCR) | 0 | 20,000 | +20,000 | $0 | $342.6K | 0.32% | +$342.6K |
| Axsome Therapeutics, Inc.(AXSM) | 4,000 | 4,000 | 0 | $319.2K | $322.0K | 0.30% | +$2.8K |
| Keros Therapeutics, Inc.(KROS) | 7,000 | 7,000 | 0 | $463.4K | $319.9K | 0.30% | -$143.5K |
| Bluebird Bio Inc | 321,200 | 311,200 | -10,000 | $411.1K | $306.3K | 0.28% | -$104.9K |
| Amicus Therapeutics Inc COM | 28,000 | 28,000 | 0 | $329.8K | $277.8K | 0.26% | -$52.1K |
| Biohaven Pharmaceutical Holding Co Ltd | 7,365 | 7,365 | 0 | $402.8K | $255.6K | 0.24% | -$147.2K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 20,000 | 40,000 | +20,000 | $101.6K | $247.2K | 0.23% | +$145.6K |
| Xencor, Inc.(XNCR) | 12,300 | 12,300 | 0 | $272.2K | $232.8K | 0.22% | -$39.4K |
| Wave Life Sciences, Inc.SHS(WVE) | 40,000 | 40,000 | 0 | $246.8K | $199.6K | 0.18% | -$47.2K |
| G1 Therapeutics Inc | 80,000 | 80,000 | 0 | $345.6K | $182.4K | 0.17% | -$163.2K |
| Inhibrx Biosciences, Inc.(INBX) | 0 | 12,110 | +12,110 | $0 | $170.6K | 0.16% | +$170.6K |
| Gossamer Bio, Inc.(GOSS) | 138,176 | 138,176 | 0 | $163.0K | $124.5K | 0.12% | -$38.6K |
| Liquidia Corporation(LQDA) | 10,000 | 10,000 | 0 | $147.5K | $120.0K | 0.11% | -$27.5K |
| InflaRx N.V.(IFRX) | 50,000 | 50,000 | 0 | $77.0K | $87.0K | 0.08% | +$10.0K |
| Cabaletta Bio, Inc.(CABA) | 10,000 | 10,000 | 0 | $170.6K | $74.8K | 0.07% | -$95.8K |
| 2seventy Bio Inc | 19,833 | 17,833 | -2,000 | $106.1K | $68.7K | 0.06% | -$37.5K |
| Ventyx Biosciences Inc | 28,800 | 28,800 | 0 | $158.4K | $66.5K | 0.06% | -$91.9K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 16,000 | 16,000 | 0 | $252.2K | $65.4K | 0.06% | -$186.7K |
| Outset Medical, Inc.(OM) | 0 | 10,000 | +10,000 | $0 | $38.5K | 0.04% | +$38.5K |
| CERo Therapeutics Holdings, Inc.CL A(CERO) | 12,972 | 12,972 | 0 | $39.8K | $3.9K | 0.00% | -$35.9K |
| Inhibrx Inc | 48,448 | 0 | -48,448 | $1.69M | $0 | — | -$1.69M |
| Pioneer Natural Resources Co | 3,800 | 0 | -3,800 | $997.5K | $0 | — | -$997.5K |
| Yield10 Bioscience Inc | 18,750 | 0 | -18,750 | $7.1K | $0 | — | -$7.1K |